Drug recall · April 14, 2021
Neomycin Sulfate Tablets recall
Why: Failed Stability Specifications: Out of Specification (OOS) result reported for microbiological assay
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Neomycin Sulfate Tablets, USP 500mg, Rx Only, 10x10 Unit dose 100 Tablets, Manufactured for: X-GEN Phamaceuticals, Inc. Big Flats, NY 14814. NDC 39822-0310-5
- Lots / codes
Lot # CFMBX, EXP 9/2022
- Quantity
- 720 100-count (10x10 blister strips)
- Company
- X-Gen Pharmaceuticals Inc., Horseheads, NY
- Distribution
- Distributed Nationwide in the USA
- Initiated
- March 19, 2021 · Voluntary: Firm initiated
- Classified
- April 8, 2021
- Reported
- April 14, 2021
- Ended
- December 7, 2022
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Neomycin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.